Clinical microbiology procedures handbook /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Washington, DC :
ASM Press,
©2010.
|
Edición: | 3rd ed and 2007 update. |
Colección: | Reference Manual, ASM Press.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Dedication
- contents
- editorial board
- how to use this handbook
- abbreviations
- preface
- acknowledgments
- reader response form
- disclaimer
- Volume 1
- Procedure coding, reimbursement, and billing compliance
- Chapter 1.1 : introduction
- Chapter 1.2 : procedure coding, reimbursement, and billing compliance
- Specimen collection, transport, and acceptability
- Chapter 2.1 : collection, transport, and manipulation of clinical specimens and initial laboratory concerns
- Aerobic bacteriology
- Chapter 3.1 : introduction to the section
- Chapter 3.2 : staining procedures
- Chapter 3.3 : processing, isolation, detection, and interpretation of aerobic bacteriology cultures
- Chapter 3.4 : blood cultures
- Chapter 3.5 : body fluid cultures (excluding blood, cerebrospinal fluid, and urine)
- Chapter 3.6 : catheter tip cultures
- Chapter 3.7 : cerebrospinal fluid cultures
- Chapter 3.8 : fecal and other gastrointestinal cultures and toxin assays
- Chapter 3.9 : genital cultures
- Chapter 3.10 : ocular cultures
- Chapter 3.11 : respiratory tract cultures
- Chapter 3.12 : urine cultures
- Chapter 3.13 : wound cultures
- Chapter 3.14 : leptospira culture
- Chapter 3.15 : mycoplasma pneumoniae, mycoplasma hominis, and ureaplasma cultures from clinical specimens
- Chapter 3.16 : guidelines for biochemical identification of aerobic bacteria
- Chapter 3.17 : biochemical tests for the identification of aerobic bacteria
- Chapter 3.18 : schemes for identification of aerobic bacteria
- Anaerobic bacteriology
- Chapter 4.1 : introduction
- Chapter 4.2 : collection and transport of clinical specimens for anaerobic culture
- Chapter 4.3 : culture media for anaerobes
- Chapter 4.4 : examination of primary culture plates for anaerobic bacteria
- Chapter 4.5 : incubation techniques for anaerobic bacteriology specimens
- Chapter 4.6 : rapid disk, spot tests, and other methods for the identification of anaerobes
- Chapter 4.7 : commercial kit overnight biochemical systems for the identification of anaerobes
- Chapter 4.8 : rapid enzymatic systems for the identification of anaerobes
- Chapter 4.9 : rapid biochemical tests (4 hours or less) for the identification of anaerobes
- Chapter 4.10 : anaerobic gram-negative bacilli
- Chapter 4.11 : anaerobic gram-positive bacilli
- Chapter 4.12 : anaerobic cocci
- Chapter 4.13 : suggestions for a practical scheme for the workup of anaerobic cultures
- Chapter 4.14 : clostridium difficile as a pathogen involved in antimicrobial agent-associated diarrhea, colitis, and pseudomembranous colitis.
- Volume 3
- Viruses and chlamydiae
- Chapter 10.1 : laboratory diagnosis of viral infections: introduction
- Chapter 10.2 : selection, maintenance, and observation of uninoculated monolayer cell cultures
- Chapter 10.3 : cell culture techniques: serial propagation and maintenance of monolayer cell cultures
- Chapter 10.4 : specimen collection and processing
- Chapter 10.5 : viral culture: isolation of viruses in cell cultures
- Chapter 10.6 : isolation of chlamydia spp. In cell culture
- Chapter 10.7 : direct detection of viruses and chlamydia in clinical samples
- Immunology
- Chapter 11.1 : immunology introduction
- Chapter 11.2 : serologic diagnosis of group a streptococcal infections
- Chapter 11.3 : detection of legionella antigen by direct immunofluorescence
- Chapter 11.4 : urinary antigen detection for legionella spp.
- Chapter 11.5 : laboratory diagnosis of syphilis
- Chapter 11.6 : detection of borrelia burgdorferi antibodies
- Chapter 11.7 : serodiagnosis of rickettsial infections
- Chapter 11.8 : immunoassay detection of shiga toxin-producing escherichia coli
- Chapter 11.9 : serodiagnosis of helicobacter pylori
- Chapter 11.10 : total viable cell counting procedure
- Chapter 11.11 : peripheral blood mononuclear cell cryopreservation method
- Chapter 11.12 : lymphocyte proliferation assay
- Chapter 11.13 : natural killer cell assays
- Chapter 11.14 : quantitation of human interleukin 4, interleukin 6, and gamma interferon
- Chapter 11.15 : flow cytometry whole-blood intracellular-cytokine assay using phorbol myristate acetate, ionomycin, and brefeldin a
- Chapter 11.16 : whole-blood lymphocyte immunophenotyping using cell surface markers by flow cytometry
- Chapter 11.17 : neutrophil function whole-blood flow cytometric test for leukocyte adhesion deficiency
- Chapter 11.18 : flow cytometric test for chronic granulomatous disease
- Chapter 11.19 : gamma interferon enzyme-linked immunospot assay
- Molecular diagnostics
- Chapter 12.1 : introduction
- Chapter 12.2 : molecular methods for direct detection of microorganisms in clinical specimens
- Chapter 12.3 : molecular methods for identification of cultured microorganisms
- Chapter 12.4 : molecular methods for epidemiologic typing of microorganisms
- Chapter 12.5 : molecular methods for antimicrobial agent resistance determination
- Chapter 12.6 : appendix 12.6-1
- unidirectional work flow and minimization of contamination
- Epidemiologic and infection control microbiology
- Chapter 13.1 : introduction
- Chapter 13.2 : laboratory support for infection control: optimization by policy and procedure
- Chapter 13.3 : policies for environmental sampling and culturing for infection control
- Chapter 13.4 : outbreak investigations: laboratory and epidemiologic concepts
- Chapter 13.5 : epidemiologic strain typing
- Chapter 13.6 : culture of hospital water for legionellaceae.
- Chapter 13.7 : culture and endotoxin assay of hemodialysis fluids
- Chapter 13.8 : culture of peritoneal dialysis fluid
- Chapter 13.9 : air cultures for fungi
- Chapter 13.10 : microbiological assay of environmental and medical-device surfaces
- Chapter 13.11 : surveillance cultures from immunocompromised hosts
- Chapter 13.12 : culture of intravascular devices
- Chapter 13.13 : culture of blood bank products
- Chapter 13.14 : microbiological assessment of orthopedic surgery sites
- Chapter 13.15 : quantitative culture of small-bowel contents
- Chapter 13.16 : phenotypic characterization of organisms for epidemiologic purposes
- Chapter 13.17 : screening for methicillin-resistant staphylococcus aureus
- Chapter 13.18 : screening for vancomycin-resistant enterococci
- Quality assurance, quality control, laboratory records, and water quality
- Chapter 14.1 : quality assessment and improvement (quality assurance)
- Chapter 14.2 : quality control
- Chapter 14.3 : laboratory records
- Chapter 14.4 : preparation and quality control of laboratory water
- Biohazards and safety
- Chapter 15.1 : introduction
- Chapter 15.2 : biological safety and biohazard prevention
- Chapter 15.3 : biohazard containment
- Chapter 15.4 : laboratory instrumentation and equipment
- Chapter 15.5 : special pathogens and employee safety
- Chapter 15.6 : packing and shipping infectious substances
- Chapter 15.7 : management of laboratory accidents
- Chapter 15.8 : management of infectious waste
- Bioterrorism
- Chapter 16.1 : general introduction to bioterrorism
- Chapter 16.2 : levels of laboratory safety
- Chapter 16.3 : packing and shipping select agents
- Chapter 16.4 : anthrax
- bacillus anthracis
- Chapter 16.5 : botulinumtoxin
- clostridium botulinum
- Chapter 16.6 : brucellosis
- brucella spp.
- Chapter 16.7 : plague
- yersinia pestis
- Chapter 16.8 : tularemia
- francisella tularensis
- Chapter 16.9 : melioidosis (burkholderia pseudomallei) and glanders (burkholderia mallei)
- Chapter 16.10 : smallpox
- variola major
- Chapter 16.11 : unknown virus
- Chapter 16.12 : q fever
- coxiella burnetii
- Chapter 16.13 : clinical laboratory bioterrorism readiness plan
- Chapter 16.14 : avian influenza
- Index.